Self-Injected Med Shows Rapid, Sustained Benefit in gMG

Topline phase 3 results show that the novel nanobody gefurulimab is safe and effective for AChR-antibody-positive myasthenia gravis, but long-term results will be key.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/self-administered-med-shows-rapid-benefit-mg-2025a1000u5x?src=rss

Author :

Publish date : 2025-11-03 15:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Self-Injected Med Shows Rapid, Sustained Benefit in gMG

Hospitalizations Tied to Supplement; A Package Full of Fingers; Harvard Explosion

Amyloid-Binding Radiotracer Spurs Hope for Better ATTR-CM Diagnosis

Related Posts

Amyloid-Binding Radiotracer Spurs Hope for Better ATTR-CM Diagnosis

Hospitalizations Tied to Supplement; A Package Full of Fingers; Harvard Explosion

FDA’s Top Drug Regulator Exits Amid Probe

Systemic Therapy for Sjögren Closer With Phase 3 Success

‘Energy Insecurity’ Tied to Anxiety, Depression Risk

SpaceX’s Starlink and other satellites face growing threat from sun

Amyloid-Binding Radiotracer Spurs Hope for Better ATTR-CM Diagnosis

Self-Injected Med Shows Rapid, Sustained Benefit in gMG

Hospitalizations Tied to Supplement; A Package Full of Fingers; Harvard Explosion

FDA’s Top Drug Regulator Exits Amid Probe

Systemic Therapy for Sjögren Closer With Phase 3 Success

‘Energy Insecurity’ Tied to Anxiety, Depression Risk

SpaceX’s Starlink and other satellites face growing threat from sun

Maldives bans smoking for younger generations

Categories

Archives